Small C - Search Results

1

Flaxseed reduces the pro-carcinogenic micro-environment in the ovaries of normal hens by altering the PG and oestrogen pathways in a dose-dependent manner.

Dikshit A, Gomes Filho MA, Eilati E, McGee S, Small C, Gao C, Klug T, Hales DB. Dikshit A, et al. Among authors: small c. Br J Nutr. 2015 May 14;113(9):1384-95. doi: 10.1017/S000711451500029X. Epub 2015 Apr 8. Br J Nutr. 2015. PMID: 25850566 Free PMC article.

2

Flaxseed and its components differentially affect estrogen targets in pre-neoplastic hen ovaries.

Dikshit A, Gao C, Small C, Hales K, Hales DB. Dikshit A, et al. Among authors: small c. J Steroid Biochem Mol Biol. 2016 May;159:73-85. doi: 10.1016/j.jsbmb.2016.02.028. Epub 2016 Feb 27. J Steroid Biochem Mol Biol. 2016. PMID: 26925929 Free PMC article.

3

Therapeutic effect of flax-based diets on fatty liver in aged laying hens.

Davis JE, Cain J, Small C, Hales DB. Davis JE, et al. Among authors: small c. Poult Sci. 2016 Nov 1;95(11):2624-2632. doi: 10.3382/ps/pew160. Epub 2016 May 3. Poult Sci. 2016. PMID: 27143762 Free PMC article.

4

Low-dose pancreatic polypeptide inhibits food intake in man.

Jesudason DR, Monteiro MP, McGowan BM, Neary NM, Park AJ, Philippou E, Small CJ, Frost GS, Ghatei MA, Bloom SR. Jesudason DR, et al. Among authors: small cj. Br J Nutr. 2007 Mar;97(3):426-9. doi: 10.1017/S0007114507336799. Br J Nutr. 2007. PMID: 17313701 Clinical Trial.

5

Peripheral oxyntomodulin reduces food intake and body weight gain in rats.

Dakin CL, Small CJ, Batterham RL, Neary NM, Cohen MA, Patterson M, Ghatei MA, Bloom SR. Dakin CL, et al. Endocrinology. 2004 Jun;145(6):2687-95. doi: 10.1210/en.2003-1338. Epub 2004 Mar 4. Endocrinology. 2004. PMID: 15001546

6

Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial.

Neary NM, Small CJ, Wren AM, Lee JL, Druce MR, Palmieri C, Frost GS, Ghatei MA, Coombes RC, Bloom SR. Neary NM, et al. Among authors: small cj. J Clin Endocrinol Metab. 2004 Jun;89(6):2832-6. doi: 10.1210/jc.2003-031768. J Clin Endocrinol Metab. 2004. PMID: 15181065 Clinical Trial.

7

Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.

Abbott CR, Small CJ, Kennedy AR, Neary NM, Sajedi A, Ghatei MA, Bloom SR. Abbott CR, et al. Brain Res. 2005 May 10;1043(1-2):139-44. doi: 10.1016/j.brainres.2005.02.065. Brain Res. 2005. PMID: 15862527

8

Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial.

Wynne K, Park AJ, Small CJ, Patterson M, Ellis SM, Murphy KG, Wren AM, Frost GS, Meeran K, Ghatei MA, Bloom SR. Wynne K, et al. Diabetes. 2005 Aug;54(8):2390-5. doi: 10.2337/diabetes.54.8.2390. Diabetes. 2005. PMID: 16046306 Clinical Trial.

9

Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.

Neary NM, Small CJ, Druce MR, Park AJ, Ellis SM, Semjonous NM, Dakin CL, Filipsson K, Wang F, Kent AS, Frost GS, Ghatei MA, Bloom SR. Neary NM, et al. Endocrinology. 2005 Dec;146(12):5120-7. doi: 10.1210/en.2005-0237. Epub 2005 Sep 8. Endocrinology. 2005. PMID: 16150917 Clinical Trial.

10

Ghrelin increases food intake in obese as well as lean subjects.

Druce MR, Wren AM, Park AJ, Milton JE, Patterson M, Frost G, Ghatei MA, Small C, Bloom SR. Druce MR, et al. Among authors: small c. Int J Obes (Lond). 2005 Sep;29(9):1130-6. doi: 10.1038/sj.ijo.0803001. Int J Obes (Lond). 2005. PMID: 15917842 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

574 results

Search Page